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BACKGROUND:  Small  intestinal  epithelial  cells  (SIEC)
may contribute to local immune regulation.
Aim: To examine production of interleukin (IL)-1a, IL-
1b and IL-6 by freshly isolated human SIEC. 
Methods: IL-1a and IL-1b mRNA in epithelial layers
(EL) prepared from small intestine and in intestinal
epithelial cell (EC) lines were examined by reverse
transcription-polymerase chain reaction. IL-1a, IL-1b
and IL-6 protein expression by SIEC was examined by
flow  cytometry  before  and  after  activation  with
lipopolysaccharide and epithelial growth factor. 
Results: IL-1a and IL-1b mRNA was detected in EL and
EC lines. Background expression of IL-1a and IL-1b
protein by SIEC was observed, which did not increase
even following activation. IL-6 protein was expressed
by SIEC, in a proportion that increased in two out of
three samples following activation.
Conclusions: IL-6 expression and the presence of IL-
1a and IL-1b mRNA  suggest  a role for  SIEC in  the
regulation of local inflammation.
Key  words:  Interleukin-1,  Interleukin-6,  Human,  Small
intestinal epithelial cells, Reverse transcriptase-polymerase
chain reaction, Intra-cytoplasmic flow cytometric analysis,
Lipopolysaccharide, Epithelial growth factor
Introduction
The  small  intestinal  immune  system  is  constantly
exposed to harmless dietary antigens, ingested patho-
gens and a variety of commensal organisms, and must
respond appropriately by activating cell-mediated or
antibody  responses  or  by  inducing  tolerance. The
epithelial layer (EL), the first barrier encountered by
antigens,  is  likely  to  play  a  role  in  determining
whether and  what  types  of  immune  responses are
induced.  A  mechanism  by  which  small  intestinal
epithelial cells (SIEC) could affect the function of the
lymphocytes present in the intestinal EL and in the
underlying lamina propria (LP) is through the produc-
tion  of  cytokines.  It  has  been  shown  that  human
colonic  epithelial  cell  (EC)  lines  or freshly  isolated
colonic EC can produce the lymphocyte growth and
activation  factors  IL-7  and  IL-15,1,2 multiple  chem-
okines,3–5 the  pro-inflammatory  cytokines  tumour
necrosis  factor-a
6,7and  IL-188,  and  the  regulatory
cytokines transforming growth factor-b
9 and IL-1010.
Due to a lesser availability of small intestinal tissue,
less is known about SIEC. It is known that SIEC can
produce IL-7,1,11 transforming growth factor-b
12 and
the  lymphocyte-attracting  chemokine  thymus-
expressed chemokine.13
IL-1 and IL-6 are pleiotropic cytokines, produced by
many  lymphoid  and non-lymphoid cells,  with func-
tions both in general metabolic processes as well as in
immune  stimulation. Their levels are increased in  a
variety of diseases.14–16 The two forms of IL-1, IL-1a
and  IL-1b,  show  24%  homology  at  the  amino  acid
level, have similar three-dimensional structures, share
biological properties and bind to the same receptors.
They have direct stimulatory effects on lymphocytes
and antigen-presenting cells (APC), as well as on the
induction of acute phase proteins and the expression
of chemokines.14 IL-6 exerts multiple  growth-induc-
ing,  growth-inhibitory  and  differentiation-inducing
effects, depending on the nature of the target cells. IL-
6  plays  roles  in T-cell  and  B-cell  development,  the
induction  of  acute-phase  protein  production  and
synergises  with  IL-1  in  inducing  T-cell  activation,
proliferation  and  differentiation  into  effector
cells.14–16 More recently, IL-6 has also been described
as a cytokine with anti-inflammatory effects.17,18 IL-6
is  involved  in  antibody  production  and  isotype
switching, and plays a critical role in the production
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Elevated levels of  both IL-1b and IL-6  are found  in
inflammatory  bowel  disease,20 and  IL-6  has  been
shown to be required for the development of T helper
(Th)1-cell-mediated murine colitis and to be involved
in  the  perpetuation  of  the  inflammatory  process
during Crohn’s disease.21,22
IL-6 is constitutively expressed by many APC and its
production is upregulated by numerous signals includ-
ing bacterial lipopolysaccharide (LPS). In contrast, IL-1
production by APC usually requires different activating
factors, depending on the APC type.23 As for human
small intestinal EL, IL-1 has not been so far detected,
and whether IL-6 can be produced by SIEC remains
controversial. Conflicting reports have described the
presence24,25 or  absence26 of  IL-6  production  by
human  SIEC.  In  the  present  study,  we  have  used
polymerase  chain  reaction amplification  of  reverse-
transcribed mRNA (RT-PCR) to ascertain whether IL-1a
and IL-1b mRNA are produced by freshly isolated EL
from the human small intestine, and have used flow
cytometry to quantify  the percentages of SIEC that
express IL-1a, IL-1b and IL-6. We have also investigated
whether the production of these cytokines by SIEC
could  be  induced  or  upregulated  by  bacterial  LPS
(known to induce IL-6 expression on other EC27 and IL-
1 on rat intestinal EC28) and epithelial growth factor
(EGF) (a trophic factor for duodenal EC29). Our results
show that IL-6 is constitutively produced by freshly
isolated SIEC and that it can be upregulated by LPS +
EGF activation. IL-1aand IL-1bmRNA is present on the
small intestinal EL but IL-1 protein was not expressed
or was detected only in a very small percentage of
SIEC, even following activation.
Materials and methods
Human tissue specimens
Duodenal biopsies (four or five biopsies per individ-
ual) were obtained from consenting patients (n = 6)
undergoing oesophagogastro-duodenoscopy. Surgical
specimens of  uninvolved ileal  tissue were obtained
from patients (n = 4) undergoing resection for colonic
cancer. Bone marrow (BM) from healthy donors (n =
3) was obtained from discarded BM bags immediately
after BM transplant. Blood was obtained from healthy
volunteers and from the patients from whom biopsies
had been obtained. Ethical approval for this study was
obtained from the Ethics Committee in St Vincent’s
University Hospital.
Cell lines and antibodies
Human colonic tumour EC lines Caco-2 and T84 were
obtained from the American Type Culture Collection
(Rockville,  MD,  USA). Anti-BerEP4  (Dako, Galstrup,
Denmark) monoclonal antibody was used to identify
EC. The anti-cytokeratin antibody CAM 5.2 (Becton-
Dickinson,  Oxford,  UK)  was  used  for  intra-cyto-
plasmic EC staining. Mouse anti-human IL-1a and IL-
1b were  purchased  from  Immunotech  (Marseille,
France), and mouse IgG2a anti-IL-6 monoclonal anti-
body  (clone  1927.311)  was  a  gift  of  R&D  Systems
(Abingdon,  UK).  fluorescein  isothiocyanate-conju-
gated  or  phyco-erythrin-conjugated  rat  anti-mouse
IgG was used as the secondary antibody. Appropriate
isotype-matched  antibodies  were  used  as  negative
controls.
Preparation of tissue samples
Small  intestinal  (ileal)  surgical  specimens  were  dis-
sected  to  fragments  smaller  than  1cm2.  EL  cell
suspensions from these surgical fragments (used for
mRNA detection) or from duodenal biopsies (used for
protein  detection)  were  prepared  by  a  method
previously described.30 This method has been shown
not to disrupt the basement membrane separating the
EL  from  the  underlying  LP.  Briefly,  samples  were
placed  in  ion-free  Hanks’  Balanced  Salt  Solution
(Gibco-BRL,  Paisley,  UK)  +  1 mM  ethylenediamine
tetraacetic acid + 1 mM dithiothreitol + 5% foetal calf
serum,  and  were  agitated  at  37°C  for  60–75min,
causing  the  release  of  single  cells  into  the  super-
natant. The tissue remaining after this EL removal was
considered LP. BM transplant bags were rinsed with
Hanks’ Balanced Salt Solution and mononuclear cells
prepared by Lymphoprep (Nycomed, Oslo, Norway)
density  gradient  centrifugation.  Peripheral  blood
mononuclear cells (PBMC) were isolated using Lym-
phoprep. Cell yield and viability was assessed using
ethidium bromide/acridine orange.
IL-1a and IL-1b RT-PCR
Total RNA was extracted by the standard guanidinium
isothiocyanate-phenol-chloroform  method,31 either
from LP tissue or from pelleted EL and BM cells, and
contaminating genomic DNA was removed by DNase.
One microgram of RNA was reverse transcribed to give
20ml of cDNA using standard procedures,32 and the
cDNA  was  purified  by  extraction  with  phenol/
chloroform/isoamyl  alcohol.  PCR  amplification  was
performed in 25ml reaction mixtures. IL-1a-specific
and  IL-1b-specific  primers were  designed based on
the cDNA published sequences.33The specific primers
for  IL-1a were  59-TGGCCAAAGTTCCAGACATG-39
and 59-TTCCAGTATCTGAAAGTCAG-39, and those for
IL-1b were  59-AGGAGAATGACCTGAGCACC-39 and
59-ATCATCTTTCAACACGCAGG-39. PCR amplification
of  b-actin, to confirm the presence of cDNA, used
the  primers  59-ATCTGGCACCACACCTTCTACAAT-
GAGCTGCG-39 and  59-CGTCATACTCCTGCTTGCT-
GATCCACATCTGC-39 (Clontech, Palo Alto, CA, USA).
All PCR reactions consisted of 94°C for 30sec, 56°C for
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18 cycles consisting of 94°C for 30sec, 54°C for 40sec
and 72°C for 40sec, and were carried out in a Hybaid
(Teddington, UK) thermocycler. In all cases where a
PCR product was not detected, 2–4ml of the reaction
product were subjected to a second round of  PCR
amplification.
Intra-cytoplasmic flow cytometry
The  expression  of  IL-1a,  IL-1b and  IL-6  by  freshly
isolated EC was  analysed  by  intra-cytoplasmic  flow
cytometric  analysis.  For  IL-1a and  IL-1b,  duodenal
samples  from  six  patients  were  analysed.  For  IL-6,
three  of  those  patients  were  analysed.  Peripheral
blood  monocytes  from  the  same  individuals  were
used as controls for cytokine expression. Monoclonal
antibody  staining  for  flow  cytometric  analysis  was
performed  as  previously  described.34 Briefly,  cells
were adjusted to 2 ´ 106 cells/ml, fixed for 15min in
2% paraformaldehyde and split into two fractions: one
for  permeabilisation  with  0.05%  saponin,  and  the
other  as  a  control.  Surface  staining  with  BerEP4
antibody  was  performed  to  identify  a  region  that
would contain > 95% EC, to be subsequently analysed
for cytokine expression. Data were acquired for flow
cytometric analysis on a Becton-Dickinson FACScan.
Anti-cytokeratin  staining  was  used  to  test  the  effi-
ciency of the permeabilisation and intra-cytoplasmic
staining  procedure.  As  positive  controls  for  the
detection  of  IL-1a,  IL-1b and  IL-6,  a  region  was
analysed that contained the monocyte population in
the  PBMC  preparations  obtained  from  the  same
patients.
LPS and EGF activation
EL single-cell suspensions from three of the samples
were cultured at densities of 1 ´ 106 cells/ml in the
presence  of  10ng/ml  of  LPS  and  20ng/ml  of  EGF
(Sigma,  Poole,  UK),  at  37°C  in  5%  CO2.  Cytokine
analysis was performed at time zero (t0) and 4h after
activation.  Monocytes  from  PBMC  activated  with
10ng/ml of LPS were used as the positive control for
cytokine upregulation.
Statistical analysis
Percentages are  expressed  as  the  mean  ±  standard
error of the mean.
Results
IL-1a and IL-1b mRNA expression by human
SIEC
RT-PCR was performed to detect expression of mRNA
specific for IL-1a and IL-1b. In all BM samples used as
positive controls, DNA products of 803 and 319 base
pair  products  were  amplified  when  IL-1a-specific
(Fig. 1A) or IL-1b-specific (Fig. 1B) primers were used,
respectively.  IL-1a mRNA  was  detected in  EL  from
three  uninvolved  surgical  specimens  out  of  four
samples  examined.  In  two  of  these  three  surgical
specimens, IL-1a mRNA was not detected in the LP
fractions, indicating that positive results obtained for
EL are not due to contamination from the LP. IL-1b
mRNA was detected in all EL and LP samples from
surgical  specimens examined (Fig.  1B). The b-actin
mRNA was readily detected in all samples.
IL-1, IL-6 in human small intestinal epithelial cells
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FIG. 1. Detection of (A, C) IL-1a mRNA and (B, D) IL-1b mRNA in (A, B) freshly isolated human small intestinal (ileal) specimens
and (C, D) human colonic EC lines by RT-PCR. (A) Lanes 1 and 2, b-actin in the EL and LP from the same patient; lane 3,
molecular weight marker (MWM); lane 4, negative control for lane 5 (no reverse transcriptase added to RNA during reverse
transcription stage); lane 5, EL IL-1a; lane 6, negative control for lane 7; lane 7, lack of IL-1a in LP; lane 8, negative control for
lane 9; lane 9, BM IL-1a; lane 10, MWM. (B) Lanes 1 and 2, b-actin in EL and LP from the same patient; lane 3, negative control
for lane 4; lane 4, EL IL-1b; lane 5, negative control for lane 6; lane 6, IL-1b in LP; lane 7, negative control for lane 8; lane 8, BM
IL-1b; lane 9, MWM. (C) Lanes 1 and 2, Caco-2 and T84 b-actin; lane 3, negative control for lane 4; lane 4, Caco-2 IL-1a; lane 5,
negative control for lane 6; lane 6, T84 IL-1a; lane 7, MWM. (D) Lanes 1 and 2, T84 and Caco-2 b-actin; lane 3, MWM; lane 4,
negative control for lane 5; lane 5, T84 IL-1b; lane 6, negative control for lane 7; lane 7, Caco-2 IL-1b mRNA; lane 8, MWM. Bp,
base pairs.IL-1a and IL-1b mRNA expression by human
intestinal EC lines
The  human  colonic  EC  lines  Caco-2  and  T84
expressed  both  IL-1a mRNA  (Fig.  1C)  and  IL-1b
mRNA (Fig. 1D), reinforcing the hypothesis that the
detection of IL-1 mRNA in the freshly isolated small
intestinal  EL  could  be  due  to  the  EC  and  not  to
potential contaminating cells in the preparations.
Constitutive IL-6 protein expression by human
SIEC but lack of IL-1a or IL-1b protein
Freshly  isolated  EC  from  six  patients  were  exam-
ined  for  IL-1a and  IL-1b,  and  three  of  these  were
also  analysed  for  IL-6  protein  expression  by  intra-
cytoplasmic  flow  cytometry.  The  yield  of  viable
SIEC,  as  assessed  by  ethidium  bromide/acridine
orange  nuclear  staining,  ranged  from  0.4 ´ 106 to
3.2  ´ 106.  The  efficiency  of  the  permeabilisation
process  was  validated  by  staining  SIEC  with  anti-
cytokeratin  antibody  (results  not  shown).  Only
BerEP4-positive cells stained positive for cytokeratin
following permeabilisation (results not shown), indi-
cating that the intracellular staining was specific. IL-
1a and  IL-1b were  found  to  be  expressed  by  only
very small  percentages of  resting SIEC (mean ± SE
of six samples, 3.3 ± 1.4% for IL-1a and 3.8 ± 1.4%
for IL-1b) and monocytes (0.9 ± 0.4% for IL-1a and
0.8 ± 0.3% for IL-1b; n = 6) (Fig. 2). In contrast, IL-
6 was detected in a considerably higher proportion
of permeabilised SIEC from all three patients exam-
ined, with 15.8, 72.5 and 22.0% SIEC expressing IL-
6  in  the  different  EC  samples  (Fig.  2).  Resting
monocytes from  the  same  individuals  (n =  3)  also
expressed  intra-cytoplasmic  IL-6  (7.9,  34.3  and
29.1%).
Effect of LPS and EGF activation on IL-1 and
IL-6 protein expression
The effect of LPS (10ng/ml) and EGF (20ng/ml) on
cytokine production by SIEC was investigated (n = 3).
Fig.  3A-I  show  flow  cytometric  staining  for  these
cytokines in one patient, for freshly isolated SIEC, for
SIEC  after  4h  activation  with  LPS  +  EGF,  and  for
monocytes from  the same individuals after  stimula-
tion for 4h with 10ng/ml of LPS. Fig. 3J-O show a
summary of results from all three patients. IL-1a and
IL-1b expression by SIEC was not induced by activa-
tion with LPS and EGF (Fig. 3D,E,J,K). Only a small
proportion of SIEC appeared to express IL-1a (6.2, 0.4
and 6.7%) (Fig. 3J) and IL-1b (3.3, 2.5 and 8.6%) (Fig.
3K) after 4h of activation. This was in contrast with
the  induction  of  these  cytokines  in  a  significant
proportion of monocytes from the same individuals
following a 4-h incubation (44.5, 55.0 and 55.1% for
IL-1a and 39.3, 64.7 and 17.5% for IL-1b, respectively)
(Fig. 3G,H,M,N). This finding appears to indicate that
IL-1 is not expressed by SIEC at any significant level,
and  that  this  expression  is  not  inducible  by  LPS,
unlike in the case of monocytes. IL-6 expression by
EC was modulated by  activation with LPS and EGF
(Fig. 3F,L). In two of three patients, the percentage of
SIEC  expressing  intracellular  IL-6  was  upregulated
(from 15.8 to 84.8% in the first patient, and from 22 to
32.1% in the second patient) following a 4-h incuba-
tion. In the third patient, 72.5% of EC were already
expressing IL-6 at t0, and this percentage fell to 53.6%
after  4h  activation  (Fig.  3L).  The  percentage  of
monocytes expressing IL-6 was consistently increased
after a 4-h activation (Fig. 3I,O) (from 7.9 to 73.6%,
from 34.3 to 77.0%, and from 29.1 to 74.1%). Thus,
upregulation  of  IL-6  by  SIEC  appeared to  follow  a
similar  pattern to  that of  monocytes following  LPS
activation, except in the case when a high percentage
of resting EC were already expressing the protein.
Discussion
Immune responses in the intestinal mucosa are partly
controlled  by  cytokines  released  in  response  to
environmental stimuli. The present study shows that
significant proportions of freshly isolated human SIEC
constitutively express IL-6 and, while mRNA for IL-1a
and IL-1b was detectable in normal small intestinal EL
samples, only a small proportion of SIEC, considered
background levels, appeared to express IL-1 protein.
IL-6 production has been shown by other groups in
histological  sections  of  small  intestinal  epithelium
using  immunohistochemistry  and  immunofluores-
cence.24,25 In freshly isolated EC from normal human
colon, IL-6 mRNA and protein have previously been
detected.7,35 However, these findings are in contrast
to those of other groups, who detected IL-6 protein36
or  mRNA37 only  in  colonic  EC  from  patients with
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FIG. 2. Intracellular expression of IL-1a (n = 6), IL-1b (n = 6)
and  IL-6  (n =  3)  by  SIEC  freshly  isolated  from  human
duodenal biopsies. Results are expressed as percentages of
SIEC expressing each cytokine, as  assessed  by flow cyto-
metry, and are compared with those obtained for monocytes
from the same patients.inflammatory  bowel  disease  but  not  from  normal
colons.26,36,37 Using  flow  cytometry  on  freshly  iso-
lated  human  duodenal  epithelial  layers,  we  have
confirmed  previous  reports24,25 that  IL-6  is  con-
stitutively produced by SIEC, and shown for the first
time that the proportions of SIEC that express IL-6 are
comparable  with  those  of  monocytes  taken  from
blood of the same individuals. Our results also show
that, when only a small proportion of freshly isolated
SIEC express IL-6, it is possible to induce the ‘in vitro’
expression of IL-6 in other SIEC by treatment for 4h
with  EGF  +  LPS.  The  discrepancies  found  in  the
different groups studying IL-6 production by intestinal
EC may relate to differences in the sensitivities of the
techniques used. Alternatively, the discrepancies may
arise as a result of differences in the tissues studied:
duodenal samples were used in the present study for
protein detection, while other groups used ileal and
colonic samples, suggesting possible differences in IL-
6  production  by  EC  from  different  regions  of  the
intestine.  The  duodenum  has  both  digestive  and
absorptive functions, while the ileum,  which forms
the distal portion of the small intestine, and the colon
are predominantly absorptive. Immunological special-
isation  of  different  regions  of  the  intestine  has
recently been demonstrated by Kunkel et al.13 This
group  found  that  the  lympho-attractant chemokine
thymus-expressed chemokine is expressed by  small
intestinal but not large intestinal EC, suggesting that
EC of the duodenum, ileum and colon may also differ
in the production of other cytokines. In support of
this notion, Shirota et al.24 reported that IL-6 staining
IL-1, IL-6 in human small intestinal epithelial cells
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FIG. 3. IL-1a, IL-1b and IL-6 expression at time zero before activation (t0) and 4h following activation. (A-I) Flow cytometric
analysis histograms  showing intracellular IL-1a,  IL-1b and IL-6 expression (A-C)  by resting  SIEC, (D-F)  by  SIEC after  4h
activation,  and  (G-I)  by  activated  monocytes  from  the  same  patient.  Open  histograms  represent  control  background
fluorescence, filled histograms show intra-cytoplasmic cytokine expression. (J-O) Summary of percentages of freshly-isolated
SIEC expressing (J) IL-1a, (K) IL-1b and (L) IL-6 at t0 and at 4h (n = 3). Results are compared with those obtained for monocytes
from the same patients for (M) IL-1a, (N) IL-1b and (O) IL-6.was more abundant in the small intestinal than the
colonic EC. Future comparisons of cytokine produc-
tion by duodenal and ileal EC may point to important
differences in the roles of these regions of the small
intestine in immune activation and oral tolerance.
The  present  study  is  consistent  with  a  previous
report that IL-1 is not produced by SIEC,26 even after
activation  by  a  combination  of  EGF  and  LPS.  In
contrast,  LPS-stimulated  monocytes  showed  a  sig-
nificant upregulation of IL-1a and IL-1b expression,
thus confirming the reliability of our flow cytometric
technique  for  IL-1  detection. Moreover,  EGF  +  LPS
upregulated  IL-6 expression by the SIEC, indicating
that the activation conditions were efficient for SIEC.
However, specific stimulatory conditions, different to
those used for IL-6, might be needed to selectively
induce  the  expression  of  IL-1  by  SIEC.  In  contrast
with the protein results, mRNA for IL-1a and IL-1b
was  detectable  in  ileal  EL  samples,  indicating  the
potential  of  SIEC  to  produce  IL-1  protein.  The
different results obtained for IL-1a for the EL and LP
from the same individual indicates that the IL-1 mRNA
detection in the EL is not due to contamination from
LP cells. The detection of IL-1a and IL-1b mRNA in
colonic EC lines (used here as a model for intestinal
EC) further supports the notion that the IL-1 mRNA
detected in the small intestinal EL would be produced
by the EC themselves. The search for IL-1 in human
colonic  EC  by  other  groups  has  yielded  before
controversial results. Jarry et al.38 have reported IL-1a
and IL-1b secretion by freshly isolated human colonic
EC. However, other studies have failed to detect IL-1
mRNA or protein in human colonic EC,7,26,35,37 even
after bacterial invasion7 or LPS, interferon-g, tumour
necrosis factor-a or IL-1b activation.35
The present findings that human SIEC can produce
IL-6, and potentially IL-1, strongly suggest a role for
SIEC  in  the  activation  or  regulation  of  immune
responses in the small intestine. The small intestine
needs  to  maintain  both  immunity  against  ingested
pathogens  and  tolerance  to  dietary  antigens  and
commensal  bacteria.  IL-6  can  polarise  the  differ-
entiation of na¨ õ ve CD4+ T cells into Th2 cells17,39 and
is essential in the development of IgA, a first line of
defence  against  many  pathogens19 at  mucosal  sur-
faces. IL-6 production by SIEC points to an essential
role  by  these  cells  in  the  maintenance  of  a Th2,
antibody-mediated environment in the small intestine.
The upregulation of IL-6 production by bacterial LPS
in two out of three cases favours the notion that SIEC
may also have a role in antibacterial immunity. IL-6 has
been implicated in Th1 responses and in inflammatory
process in human Crohn’s disease and murine models
of colitis,21,22 suggesting that IL-6 may potentiate the
inflammatory role elicited by other cytokines such as
IL-1. The presence of IL-1a and IL-1b mRNA in SIEC
makes these cells potential inducers of inflammatory
responses. Our failure to detect significant expression
of IL-1 protein by SIEC suggests that these cells have
distinct functions to other cells involved in immune
activation such as monocytes. Alternatively, SIEC may
produce IL-1 but require different stimulatory signals
than other cells. Future, more extensive, analyses of
SIEC activation may confirm whether these cells can
produce  IL-1.  Given  that  the  main  function  of  the
small intestine is digestion and absorption of nutri-
ents, the environment is predisposed to dampen an
inflammatory response. We suggest that, under cer-
tain conditions in vivo, such as disease or infection,
SIEC may be induced to produce IL-1 protein and be
key  cells in  the initiation  of  inflammatory  immune
responses  against  harmful  antigens  in  the  small
intestine.
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